Upon awakening from an eight-month coma, a man was fatally struck by a pickup truck.
Florida resident Drew Kohn gained notoriety as a “miracle” guy in 2017 after he survived an accident.
Tragically, though, the 29-year-old was struck and killed on July 26, 2024—more than six years after waking up from a 244-day coma.
Yolanda Osborne-Kohn, his mother, said to WTLV, “God granted my request, and I’m not angry.”
“I’m not irate. I’m content. After seven years, I distinctly recall telling myself, “Thy will be done,” while seated on Drew’s hospital bed.
Kohn was hit by a pickup truck at around 5:30 in the morning while he was allegedly strolling east on a Jacksonville, Florida, street.
The Jacksonville Sheriff’s Office released the following statement to People magazine: “At that time, it was dark, and the pedestrian was not wearing reflective clothing.”Sadly, the pedestrian was struck in the outer lane by the pick-up truck driver who failed to see him. The pickup truck’s driver pulled over and dialed 911. After arriving on the scene, Jacksonville Fire and Rescue (JFRD) declared the person dead.
The driver of the truck remained at the scene, according to the authorities, and no one else was harmed or engaged.
It was also revealed that the medical examiner’s office and traffic homicide detectives had both been on the scene and were conducting their own investigations.
Kohn’s family established a GoFundMe page after the accident to assist with paying for his burial expenses as well as “medical expenses he accumulated.” As of this writing, more than $18,000 has been raised.
He was only “days away from his 30th birthday,” according to the fundraiser’s description, which also calls him a “modern-day miracle.”
Days before becoming 23 years old, years before Kohn’s tragic death, he had been in a terrible accident that had left him unconscious.
On July 17, 2017, Kohn’s motorcycle crashed into a car while he was riding it to the gym.
According to WTLV, the 22-year-old was taken to the hospital in a critical condition and placed in a coma due to a traumatic head injury, shattered shoulder, impaled lungs, and other injuries.
“Doctors thought he was brain dead and would never walk or talk again,” the GoFundMe website continues.
Oshnourne-Kohn told WTLV that, considering the likelihood of her son’s death, medical professionals advised her to gather her son’s organs for donation. She did, however, trust in God.
“My faith gave me the boldness to speak up and push back and let them know ‘You’re not getting a toenail or an eyelash,’” the mother stated.
When Kohn emerged from a coma nearly a year after the crash, First Coast News reports that he said, “Yeah, Mom, I’m okay.” Mom, you are loved.”
Kohn gradually made a full recovery, going on to call himself “a modern-day miracle” and say, “My story represents never giving up hope.” God is the source of all possibilities. All I want to do is encourage them to never give up.
Kohn “is now completely healed and free,” according to the fundraising.
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply